APA (7th ed.) Citation

Nawa, H., Hamano, H., Niimura, T., Miyata, K., Yagi, K., Goda, M., . . . Ishizawa, K. (2022). Evaluation of the potential complication of interstitial lung disease associated with antifibrotic drugs using data from databases reporting spontaneous adverse effects. CTS: Clinical & Translational Science, 15(12), 2982. https://doi.org/10.1111/cts.13419

Chicago Style (17th ed.) Citation

Nawa, Hideki, Hirofumi Hamano, Takahiro Niimura, Koji Miyata, Kenta Yagi, Mitsuhiro Goda, Yoshito Zamami, and Keisuke Ishizawa. "Evaluation of the Potential Complication of Interstitial Lung Disease Associated with Antifibrotic Drugs Using Data from Databases Reporting Spontaneous Adverse Effects." CTS: Clinical & Translational Science 15, no. 12 (2022): 2982. https://doi.org/10.1111/cts.13419.

MLA (9th ed.) Citation

Nawa, Hideki, et al. "Evaluation of the Potential Complication of Interstitial Lung Disease Associated with Antifibrotic Drugs Using Data from Databases Reporting Spontaneous Adverse Effects." CTS: Clinical & Translational Science, vol. 15, no. 12, 2022, p. 2982, https://doi.org/10.1111/cts.13419.